6-CHLORO-5-METHYL-4H-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-ONE
- $200 - $874
- Product name: 6-CHLORO-5-METHYL-4H-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-ONE
- CAS: 41081-76-9
- MF: C6H5ClN4O
- MW: 184.58
- EINECS:
- MDL Number:MFCD03725082
- Synonyms:BAS 06172282;SBB010721;ZINC00798572;TIMTEC-BB SBB010721;6-CHLORO-5-METHYL-4H-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-ONE;6-chloro-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one;6-chloro-5-methyl-1H-[1,2,4]triazolo[5,1-b]pyrimidin-7-one;6-Chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7(1H)-one
3 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11127281
- Product description6-Chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010923
- Product description6-Chloro-5-methyl-4H-[1,2,4]triazolo[1,5-a]-pyrimidin-7-one
- Packaging500mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010923
- Product description6-Chloro-5-methyl-4H-[1,2,4]triazolo[1,5-a]-pyrimidin-7-one
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11127281 | 6-Chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 010923 | 6-Chloro-5-methyl-4H-[1,2,4]triazolo[1,5-a]-pyrimidin-7-one | 500mg | $200 | 2021-12-16 | Buy |
Matrix Scientific | 010923 | 6-Chloro-5-methyl-4H-[1,2,4]triazolo[1,5-a]-pyrimidin-7-one | 1g | $308 | 2021-12-16 | Buy |
Properties
Melting point :>350 °C
Boiling point :436.3±48.0 °C(Predicted)
Density :1.79±0.1 g/cm3(Predicted)
pka :-0.28±0.60(Predicted)
Boiling point :436.3±48.0 °C(Predicted)
Density :1.79±0.1 g/cm3(Predicted)
pka :-0.28±0.60(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|